Equities

Baird Medical Investment Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BDMD:NAQ

Baird Medical Investment Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.9204
  • Today's Change0.016 / 1.74%
  • Shares traded74.64k
  • 1 Year change-84.61%
  • Beta-1.0622
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.

  • Revenue in USD (TTM)31.86m
  • Net income in USD-3.12m
  • Incorporated2023
  • Employees143.00
  • Location
    Baird Medical Investment Holdings Ltd18/F, Ovest, 77 Wing Lok StreetGUANGZHOU ChinaCHN
  • Phone+86 2 082185926
  • Websitehttps://ir.bairdmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Femasys Inc2.06m-19.80m28.36m69.00--5.04--13.76-0.7198-0.71980.070.09630.12940.19734.3429,876.81-124.24-63.09-214.46-74.3063.0566.63-960.53-961.820.6131-9.720.5982--51.9711.89-32.07--4.01--
PetVivo Holdings Inc1.41m-9.65m28.54m24.00--6.70--20.26-0.402-0.4020.05920.12690.33370.626110.3758,701.67-224.88-195.28-343.15-346.3378.8874.58-673.99-1,163.491.45-4.230.00--16.91216.0823.33--49.21--
Wellgistics Health Inc34.08m-77.75m28.58m31.00--4.20--0.8386-1.32-1.320.61610.07580.6293.6317.53---143.52---365.21--7.86---228.17--0.1628-16.420.7854-------136.77------
Myomo Inc41.64m-12.02m29.71m184.00--2.03--0.7136-0.2885-0.28851.010.38051.653.969.23226,321.70-47.71-55.96-70.30-77.4066.5669.74-28.86-52.922.10--0.2148--69.1753.3624.10--92.10--
Vivos Inc48.63k-3.01m30.85m10.00--14.15--634.36-0.0068-0.00680.00010.00480.0275--10.03---170.12-166.49-178.25-242.01-127.332.81-6,191.01-11,105.9819.81--0.00--43.5924.13-0.5424------
Ekso Bionics Holdings Inc14.75m-10.66m31.76m61.00--2.54--2.15-5.70-5.707.253.690.57991.362.27241,786.90-41.02-41.01-60.62-52.9053.4852.89-70.74-97.041.09--0.3055---1.945.1925.45---9.22--
Vaso Corp89.11m2.59m32.55m298.0012.601.159.820.36530.01470.01470.50650.16051.1334.0210.28299,030.203.277.375.3614.5660.9159.172.915.991.61--0.01--7.092.82-80.21--3.81--
Baird Medical Investment Holdings Ltd31.86m-3.12m33.23m143.00--0.675--1.04-0.1128-0.11281.221.340.45523.270.8459222,797.30-4.48---7.64--86.94---9.84--1.67-0.3230.3856--17.74--18.57------
Guided Therapeutics Inc178.00k-2.80m33.43m4.00------187.82-0.0386-0.03860.0025-0.06750.16540.108344.5044,500.00-244.61-129.80----62.9244.19-1,478.65-4,184.720.0334-4.13-----92.86-27.9331.07------
Modular Medical Inc0.00-24.22m34.33m54.00--3.08-----0.5081-0.50810.000.14340.00----0.00-222.79-171.42-294.38-207.14------------0.00-------7.75--57.07--
RenovoRx Inc928.00k-11.11m34.85m10.00--4.31--37.55-0.4375-0.43750.03120.22040.0874----92,800.00-104.58-121.57-126.33-166.5067.78---1,196.66-90,830.235.68--0.00------13.86------
TELA Bio Inc77.06m-39.00m35.02m209.00--20.73--0.4545-0.8863-0.88631.750.03861.342.016.85368,684.20-68.06-51.29-96.57-60.7067.2366.26-50.61-88.022.62-7.250.9638--18.5635.0218.91---18.18--
Precipio Inc22.80m-1.25m35.69m54.00--2.59147.471.57-0.835-0.83514.637.881.2018.2615.31422,222.20-6.58-38.01-8.60-46.9844.8233.80-5.50-71.341.10-24.190.074--21.9542.7426.70--32.31--
Neuroone Medical Technologies Corp12.10m-3.61m37.07m18.00--5.20--3.06-0.0784-0.07840.30120.14141.501.6316.79672,094.40-44.63-113.64-61.95-152.0867.3060.94-29.80-223.443.47--0.1519--250.3544.4170.73---7.76--
Icecure Medical Ltd2.98m-15.29m38.01m64.00--4.08--12.78-0.2586-0.25860.05010.13490.1960.823524.3946,484.38-100.74-61.14-155.92-77.1135.0650.17-513.95-343.951.90--0.00--1.9215.35-4.55---6.51--
Data as of Feb 06 2026. Currency figures normalised to Baird Medical Investment Holdings Ltd's reporting currency: US Dollar USD

Institutional shareholders

8.88%Per cent of shares held by top holders
HolderShares% Held
Exos Asset Management LLCas of 13 May 20252.75m7.71%
Highbridge Capital Management LLCas of 30 Sep 2025125.00k0.35%
Periscope Capital, Inc.as of 30 Sep 2025125.00k0.35%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 202548.29k0.14%
Citadel Securities LLCas of 30 Sep 202546.53k0.13%
UBS Securities LLCas of 31 Dec 202533.91k0.10%
Geode Capital Management LLCas of 30 Sep 202525.44k0.07%
Virtu Americas LLCas of 30 Sep 202514.04k0.04%
Wolverine Asset Management LLCas of 30 Sep 2025205.000.00%
Tower Research Capital LLCas of 30 Sep 20250.000.00%
More ▼
Data from 13 May 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.